Connect with us

Media & Technology

Penny Stock Unicorn HUMBL (TSNPD) (HMBL) Reverse Split, Name Change, & Zoom Call Update

Published

2 years ago

on

HUMBL® (TSNPD) has been moving steadily higher since its 4 for 1 reverse stock split on Friday as well as the name change from Tesoro Enterprises to HUMBL. The ticker symbol has temporarily changed to TSNPD to reflect the RS and there will be a ticker symbol change to HMBL within the next 2 weeks to reflect the name change to HUMBL.  During the Zoom call on Friday management touted the reverse split as a way to force the shorts to cover; investors also noted that the much higher price point would make it much easier for the Company to up list to a national exchange. As of Friday TSNPD, was trading in the $1.20 pre-split range and the stock traded well over $50 million on the day. On Friday evening CEO Brian Foote and Reverse Merger Whizz and architect of the HUMBL spac George Sharp hosted a Zoom call with investors with at least 1,500 investors initially calling in.  Mr. Sharp made it clear management does not anticipate any dilution during Calander 2021 and is focused on creating more shareholder value. CEO Brian Foote stated the app will be released within the next 4-6 weeks. The George Sharp brokered Reverse Merger (RM) SPAC runner has become the posterchild of the new otc bulletin boards where anything is possible and nothing is impossible. TSNP regularly trades several hundred million dollars in dollar volume per day recently topping $375 million in 1 day. From current levels invetors are looking for an all out blue sky breakout over previous highs.

$TSNPD is the unicorn penny stock that has skyrocketed up the charts in recent months as we enter a new digital era where Bitcoin is king and paper currencies are losing their value. HUMBL has real potential to become the standard in online payments disrupting PayPal, Venmo and Zella and is disrupting entrenched regional banks, wire services, and other finance providers in emerging markets such as Latin America, the Caribbean, Asia, and Africa. The HUMBL® Mobile App delivers borderless transactions, by integrating multiple currencies, payment methods, banks, and financial services providers into one-click for the customer. HUMBL CEO Brian Foote, well known in the crypto space recently said: “We didn’t build HUMBL for the 450 million digital customers using Apple Pay®, but for the 7 billion people for whom money has a totally different set of global pathways, access points, and cost structures.”   

HUMBL® (TSNPD) is a new, Web 3 platform being developed to seamlessly connect consumers and merchants in the digital economy, across its HUMBL® Mobile Applications, HUMBL Marketplace and HUMBL Financial divisions. HUMBL® Mobile Applications will deliver more seamless global transactions, by integrating multiple currencies, payment methods and financial services into reduced clicks for the customer. HUMBL Marketplace™ was developed to connect customers and merchants online, in improved global commerce, deal discovery and blockchain tokenization programs. HUMBL Financial™ has developed new software and algorithms for the digital asset trading markets, which are a new global market for blockchain technologies, and will also offer other credit, lending and financial services. 

As Microcapdaily reported on TSNP last week: “There is a lot to get excited about on HUMBL as we enter a new digital era where Bitcoin is gold and paper currencies quickly lose value. HUMBL is quickly disrupting entrenched regional banks, wire services, and other finance providers in emerging markets such as Latin America, the Caribbean, Asia, and Africa. HUMBL has real potential to become the standard in online payments disrupting PayPal, Venmo and Zella along the way. The HUMBL® Mobile App delivers borderless transactions, by integrating multiple currencies, payment methods, banks, and financial services providers into one-click for the customer. HUMBL CEO Brian Foote, well known in the crypto sphere stated: “We didn’t build HUMBL for the 450 million digital customers using Apple Pay®, but for the 7 billion people for whom money has a totally different set of global pathways, access points, and cost structures.”  HUMBL is very well funded moving forward; TSNP is a clean shell and all liabilities were paid by the outgoing CEO. Since TSNP is a high-flying unicorn it’s easy for the Company to raise funds. Starting as early as November of last year the Company was able to raise significant funds through the cash sale of warrants and currently HUMBL has access to at least $50 million in equity funding.”  

HUMBL is very well funded moving forward; TSNP is a clean shell and all liabilities were paid by the outgoing CEO. Since TSNP is a high-flying unicorn it’s easy for the Company to raise funds. As the merger was being completed last year HUMBL was able to consummate November 23, 2020 agreements to raise funding through the cash sale of warrants. As these warrants are exercised, HUMBL will access up to $50 million in equity funding, to be used for marketing of the HUMBL global brand; the HUMBL® mobile app and HUMBL Hubs® merchant software; as well as distribution and partnerships around the world. 

Investor sentiment on TSNP is very high:

https://twitter.com/TheHUMBLship/status/1365137284740378624

To get an inside look at HUMBL Subscribe to Microcapdaily.com immediately by entering your Email below

TSNP

HUMBL is led by CEO Brian Foote is well known in the crypto community and brings with him twenty years of consumer technology experience, having launched a number of top ranked global technology products at companies like Epson, where he was twice named to the Innovators Team Award for his work across merchant partners such as Amazon, Walmart, Costco, Target and Best Buy. In recent months Brian Foote has reduced the share count by at least 800 million and pledged not to dilute the stock in the future.  

Microcapdaily has been reporting on the historic rise of TSNP from triple zeroes to $1.93 per share since the very beginning. On November 15, 2020 when TSNP was trading for well below a penny we reported: “Tesoro Enterprises, Inc. (OTCMKTS: TSNP) is making a spectacular run up the charts in recent weeks quickly transforming into a volume leader and one of the top most traded stocks in small caps. TSNP started off in triple zero land but has gone parabolic since than quickly attracting legions of new shareholders who continue to bid the stock higher. Reverse Merger stocks (RM) are easily among the most exciting and explosive stocks in small caps rivaling only biotechs in their ability to make historic gains. TSNP is the perfect merger candidate; a clean shell with virtually no debt and the new Company HUMBL is a major mobile payments player with a first-class management team with team members coming from companies like Western Union, Moneygram, Visa, American Express, Epson, Microsoft, Facebook and Qualcomm and was recently named a Forbes “Rising Startups to Watch” The whole deal is being shepherded by George Sharp, a reverse merger whizz and someone known for doing it right. 

On Thursday February 5, FINRA approved and processed the Company’s corporate actions, as requested, and has had its name changed to HUMBL, Inc. In addition to the change in the company’s name, HUMBL has executed a one for four (1:4) reverse split of its common stock, and made other changes to its share structure, including the creation of restricted preferred classes of shares which will be issued to former members of HUMBL, LLC and prospective investors of HUMBL. The authorized number of shares stated reflects these preferred shares on a presumed fully diluted basis. 

 

HUMBL Named a Forbes 2020 Rising Startup To Watch

In discussion about the reverse split, HUMBL’s COO and Corporate Secretary, Jeffrey Hinshaw, stated, “The company’s Board of Directors concluded that it was important to quell the volatility in the share price. Prospective investors and current shareholders were concerned that it was difficult to pinpoint the true value of the common shares. Furthermore, this will force any outstanding short positions to cover their position. The board was also sympathetic to the need not to wipe out the holdings of the shareholders, and therefore determined that this small reverse split would satisfy both requirements. As a result of the reverse split, HUMBL’s stock symbol will change to “TSNPD” on February 25, 2021 and then to “HMBL” on March 26, 2021. 

On Friday, February 26 HUMBL held a shareholder conference call on Friday evening at 5pm on ZOOM. CEO Brian Foote and Reverse Merger Whizz and architect of the HUMBL spac George Sharp hosted the call with investors with at least 1,500 investors initially calling in.  Mr. Sharp made it clear management does not anticipate any dilution during Calander 2021 and is focused on creating more shareholder value. CEO Brian Foote stated the app will be released within the next 4-6 weeks. 

https://twitter.com/Rebecca741776/status/1365524939252637699

For More on HUMBL Subscribe Right Now!

HUMBL® (TSNPD) has been moving steadily higher since its 4 for 1 reverse stock split on Friday as well as the name change from Tesoro Enterprises to HUMBL. The ticker symbol has temporarily changed to TSNPD to reflect the RS and there will be a ticker symbol change to HMBL within the next 2 weeks to reflect the name change to HUMBL.  During the Zoom call on Friday management touted the reverse split as a way to force the shorts to cover; investors also noted that the much higher price point would make it much easier for the Company to up list to a national exchange. As of Friday TSNPD, was trading in the $1.20 pre-split range and the stock traded well over $50 million on the day. On Friday evening CEO Brian Foote and Reverse Merger Whizz and architect of the HUMBL spac George Sharp hosted a Zoom call with investors with at least 1,500 investors initially calling in.  Mr. Sharp made it clear management does not anticipate any dilution during Calander 2021 and is focused on creating more shareholder value. CEO Brian Foote stated the app will be released within the next 4-6 weeks. The George Sharp brokered Reverse Merger (RM) SPAC runner has become the posterchild of the new otc bulletin boards where anything is possible and nothing is impossible. TSNP regularly trades several hundred million dollars in dollar volume per day recently topping $375 million in 1 day. From current levels invetors are looking for an all out blue sky breakout over previous highs. $TSNPD is the unicorn penny stock that has skyrocketed up the charts in recent months as we enter a new digital era where Bitcoin is king and paper currencies are losing their value. HUMBL has real potential to become the standard in online payments disrupting PayPal, Venmo and Zella and is disrupting entrenched regional banks, wire services, and other finance providers in emerging markets such as Latin America, the Caribbean, Asia, and Africa. The HUMBL® Mobile App delivers borderless transactions, by integrating multiple currencies, payment methods, banks, and financial services providers into one-click for the customer. HUMBL CEO Brian Foote, well known in the crypto space recently said: “We didn’t build HUMBL for the 450 million digital customers using Apple Pay®, but for the 7 billion people for whom money has a totally different set of global pathways, access points, and cost structures.” We will be updating on TSNP when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TSNP.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in TSNP either long or short and we have not been compensated for this article.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum

Published

13 hours ago

on

June 4, 2023

By

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc. chose a lead candidate.

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc., a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, chose a lead candidate aimed at an undisclosed tumor-associated antigen for further development towards clinical settings.

GAMMABODY™ PLATFORM

LAVA primarily focuses on revolutionizing cancer therapy by developing its Gammabody™ platform. This platform enables them to create bispecific gamma delta T cell engagers that can activate a specific subset of gamma-delta T cells called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells. By utilizing this approach, they aim to enhance the natural recognition of tumors, guide Vγ9Vδ2 T cells to target the tumor cells directly and trigger a cascade of immune responses.

To Discover the Inside Scoop on LVTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What sets their Gammabody™ drug candidates apart is their exceptional performance and safety profiles observed in preclinical studies. Compared to other bispecific T cell engager approaches, their candidates have demonstrated superior efficacy and preferred targeting tumor cells. This targeted approach has the potential to minimize toxicity in healthy tissues.

In May 2020, LAVA entered into a research collaboration and license agreement with Janssen, a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration aimed to discover and develop novel bispecific antibody-based gamma delta T cell engagers for cancer treatment. The agreement was facilitated by Johnson & Johnson Innovation, emphasizing their commitment to fostering innovation in the field.

As part of the collaboration, LAVA had the opportunity to receive potential milestone payments and royalties based on the successful development, regulatory approvals, and commercialization of the candidates. This incentivized LAVA to actively pursue the discovery and advancement of promising lead candidates. 

The collaboration represents a remarkable milestone many early-stage biotech companies aspire to achieve. Partnering with a program brings numerous benefits, including reduced risk of dilution through milestone payments as the trials advance and streamlined commercialization once the product receives approval.

Under the terms of the agreement, Janssen will assume responsibility for the selected candidate’s future clinical development, manufacturing, and commercialization. This includes bearing the costs and expenses associated with these activities.

Stephen Hurly, LAVA Therapeutics’s president and chief executive officer, expressed satisfaction with Janssen’s selection of a lead candidate for clinical studies. He emphasized LAVA’s pioneering role in developing gamma-delta bispecific antibodies through their proprietary Gammabody platform. This platform and LAVA’s extensive expertise in bispecific antibody development position them at the forefront of advancing novel therapies for cancer patients.

In summary, LAVA Therapeutics’ collaboration with Janssen has reached a significant milestone in selecting a lead candidate for further development toward clinical studies. This progress underscores LAVA’s dedication to leveraging its Gammabody platform and expertise in bispecific antibody development to revolutionize cancer treatment.

We will update you on LVTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by 3D Animation Production Company from Pixabay

Continue Reading

Featured

Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI

Published

7 days ago

on

May 29, 2023

By

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com.

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com. The implementation of this innovative AI tool, powered by chatGPT-style Large Language Models (LLMs), has resulted in a surge of 105% in the company’s stock price and sparked tons of investor interest. The company has a 3.28M float and, at the time of writing, has traded 20x that amount, with a colossal 60M shares exchanging hands.

Revolutionizing User Experience and Driving Stock Surge

With the integration of AI search on MightyDeals.com, customers can now use natural language to describe the products they seek, simplifying the buying process. The AI tool utilizes contextual understanding and description analysis of hundreds of active deals to generate instant search results based on users’ queries. By enhancing the user experience, Onfolio Holdings anticipates increased user return rates, higher site interaction rates, and elevated revenues for MightyDeals.com. This groundbreaking development has attracted positive attention, significantly increasing Onfolio Holdings’ stock price.

To Discover the Inside Scoop on ONFO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Evaluating Financial Performance

While the stock surge indicates investor enthusiasm, assessing Onfolio Holdings’ financial performance is crucial for comprehensive investment analysis. The positive earnings growth of +44.44% and revenue growth of +22.74% contribute to the company’s optimistic outlook. However, investors should be cautious of the negative net profit margin of -190.75% and the lack of available price/book ratio data. Monitoring the company’s financial performance leading up to the next reporting date on August 30, 2023, is advised to understand its profitability and overall stability better.

Investment Outlook and Future Prospects

Considering the stock surge and optimistic price forecasts, Onfolio Holdings has promising prospects. Analysts offer a median target price of $3.00 for the company’s stock, signaling an expectation of significant growth within the next 12 months. However, it is essential to note that Onfolio Holdings operates at a loss. Investors should thoroughly evaluate the company’s long-term growth potential and weigh the potential returns against the inherent risks before making investment decisions.

About MightyDeals.com

Mighty Deals is a free daily deals website aimed at creative professionals focusing on products and services for web designers and developers. The site offers fantastic deals on quality fonts, templates, apps, add-ons, plug-ins, ebooks, icons, and more. The site provides discounts on packages which usually range between 50%-97% off but are only available for a limited time. MightyDeals.com boasts an exceptional return rate from its users and is one of Onfolio Holdings’ highest revenue-generating subsidiaries.

About Onfolio Holdings Inc.

Onfolio acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires firms that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by our existing team or have strong management teams largely in place. The Company excels at finding acquisition opportunities where the seller has not fully optimized their business. Onfolio’s experience and skillset allow it to add increased value to these existing businesses.

Conclusion

Onfolio Holdings’ introduction of the generative AI search function for MightyDeals.com has increased the company’s stock price, reflecting the market’s positive response to this innovative technology. The enhanced user experience and the potential for increased revenues have positioned Onfolio Holdings as a leader in the tech industry. However, investors must carefully consider the company’s financial performance and evaluate its long-term growth potential before making investment decisions. Monitoring the company’s performance to the next reporting date will provide valuable insights into its financial health and stability.

We will update you on ONFO when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by James from Pixabay

Continue Reading

Featured

Enveric Biosciences (NASDAQ: ENVB) Pioneering the Future of Anxiety Disorder Treatment

Published

2 weeks ago

on

May 19, 2023

By

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news.

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news. The United States Patent and Trademark Office has granted them a notice of allowance for their patent application concerning a groundbreaking chemical compound called EB-373. This compound is being developed to address the treatment of anxiety disorders.

The forthcoming patent, titled “C4-Carbonothioate-Substituted Tryptamine Derivatives and Methods of Using,” encompasses claims for the composition of matter of a family of revolutionary prodrug derivatives of psilocin. Enveric’s lead product candidate, EB-373, stands out among these derivatives. A Notice of Allowance signifies that the USPTO has determined that a patent should be granted based on the submitted application.

To Discover the Inside Scoop on ENVB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Enveric’s commitment to innovation extends beyond EB-373. They have also submitted additional patent applications to the USPTO, exploring psilocin prodrugs with unique crystalline molecular structures. Moreover, they have taken proactive steps to pursue global coverage of the EVM201 and EVM301 Series through companion Patent Cooperation Treaty and non-US national patent applications. Encouragingly, positive International Search Reports and written opinions have been received under the Patent Cooperation Treaty for most of these applications.

Joseph Tucker, Ph.D., Enveric’s director and CEO, underlined the significance of the USPTO’s favorable decision concerning their lead candidate, EB-373. He highlighted the innovative designs of their psilocin prodrugs within the EVM201 series, differentiating them from conventional counterparts like psilocybin. These novel designs hold the potential to deliver more rapid therapeutic effects, precise control, and reduced gastrointestinal side effects. Tucker emphasized that securing a robust intellectual property portfolio for their new chemical entity prodrugs is pivotal to Enveric’s value proposition and integral to their business strategy of developing cutting-edge small-molecule therapeutics to address mental health disorders.

We will update you on ENVB when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gino Crescoli from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.